Literature DB >> 11774322

Biocompatibility studies on biodegradable polyester-based composites of human osteoblasts: a preliminary screening.

L Calandrelli1, B Immirzi, M Malinconico, G Orsello, M G Volpe, F Della Ragione, V Zappia, A Oliva.   

Abstract

A series of biodegradable composites with natural hydroxyapatite, designed for possible use in orthopedics applications, were preliminarily screened for biocompatibility by employing primary cultures of human osteoblasts in a direct contact method. The cells were seeded at low density onto the materials under investigation and allowed to grow for 2 weeks. They then were analyzed for morphology, proliferation, viability, alkaline phosphatase activity (AP), osteocalcin (OC) production, and extracellular matrix mineralization. The results showed that all materials have good biocompatibility. Cell viability tests demonstrated that in all cases the values were comparable to the control, and the addition of hydroxyapatite always resulted in an enhancement of performance with respect to the plain polymer. AP and OC analysis confirmed that all composites allowed the expression of phenotypic markers. Scanning electron microscopy provided direct evidence of intense cell adhesion and proliferation on the tested materials. Copyright 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 611-617, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774322     DOI: 10.1002/jbm.10014

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  2 in total

1.  In vitro degradation and cytocompatibility evaluation of novel soy and sodium caseinate-based membrane biomaterials.

Authors:  G A Silva; C M Vaz; O P Coutinho; A M Cunha; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2003-12       Impact factor: 3.896

2.  Isolation and Osteogenic Differentiation of Rat Periosteum-derived Cells.

Authors:  Heidi Andrea Declercq; Leo Isabelle De Ridder; Maria Jozefa Cornelissen
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.